1999
Use of rituximab and irradiated donor-derived lymphocytes to control Epstein–Barr virus-associated lymphoproliferation in patients undergoing related haplo-identical stem cell transplantation
McGuirk J, Seropian S, Howe G, Smith B, Stoddart L, Cooper D. Use of rituximab and irradiated donor-derived lymphocytes to control Epstein–Barr virus-associated lymphoproliferation in patients undergoing related haplo-identical stem cell transplantation. Bone Marrow Transplantation 1999, 24: 1253-1258. PMID: 10642818, DOI: 10.1038/sj.bmt.1702052.Peer-Reviewed Original ResearchMeSH KeywordsAdultAntibodies, MonoclonalAntibodies, Monoclonal, Murine-DerivedAntigens, ViralAntineoplastic AgentsBlood Component TransfusionBlood DonorsDNA, ViralGraft vs Host DiseaseHematologic NeoplasmsHematopoietic Stem Cell TransplantationHerpesvirus 4, HumanHumansImmunosuppression TherapyLymphocytesLymphoproliferative DisordersMalePolymerase Chain ReactionRituximabConceptsEpstein-Barr virus-associated lymphoproliferative disorderStem cell transplantationEBV DNA titersB cell populationsCell transplantationTherapeutic strategiesEpstein-Barr virus-associated lymphoproliferationHaplo-identical stem cell transplantationEffective alternative therapeutic strategyAllogeneic stem cell transplantationCourses of rituximabDonor-derived lymphocytesPost-transplant immunosuppressionMonoclonal B-cell populationCD20 monoclonal antibodyCell populationsAlternative therapeutic strategiesImmunosuppressive medicationsSevere GVHDHost diseaseLymphocyte infusionPost transplantFatal complicationCurative therapyLymphoproliferative disorders
1985
Bone marrow transplantation for paroxysmal nocturnal hemoglobinuria: eradication of the PNH clone and documentation of complete lymphohematopoietic engraftment.
Antin JH, Ginsburg D, Smith BR, Nathan DG, Orkin SH, Rappeport JM. Bone marrow transplantation for paroxysmal nocturnal hemoglobinuria: eradication of the PNH clone and documentation of complete lymphohematopoietic engraftment. Blood 1985, 66: 1247-50. PMID: 3904867, DOI: 10.1182/blood.v66.6.1247.bloodjournal6661247.Peer-Reviewed Original ResearchConceptsParoxysmal nocturnal hemoglobinuriaBone marrow transplantationConditioning regimenMarrow transplantationMarrow aplasiaPNH cloneNocturnal hemoglobinuriaPretransplant conditioning regimenCurative therapyAntithymocyte serumComplete engraftmentMarrow graftingSuccessful treatmentAbnormal clonePatientsHematopoietic stem cellsRBC typingTransplantationRegimenCell linesAplasiaDNA sequence polymorphism analysisEngraftmentHemoglobinuriaStem cellsBone Marrow Transplantation for Paroxysmal Nocturnal Hemoglobinuria: Eradication of the PNH Clone and Documentation of Complete Lymphohematopoietic Engraftment
Antin J, Ginsburg D, Smith B, Nathan D, Orkin S, Rappeport J. Bone Marrow Transplantation for Paroxysmal Nocturnal Hemoglobinuria: Eradication of the PNH Clone and Documentation of Complete Lymphohematopoietic Engraftment. Blood 1985, 66: 1247-1250. DOI: 10.1182/blood.v66.6.1247.1247.Peer-Reviewed Original ResearchParoxysmal nocturnal hemoglobinuriaBone marrow transplantationConditioning regimenMarrow transplantationMarrow aplasiaPNH cloneNocturnal hemoglobinuriaPretransplant conditioning regimenCurative therapyAntithymocyte serumComplete engraftmentMarrow graftingSuccessful treatmentAbnormal clonePatientsHematopoietic stem cellsRBC typingTransplantationRegimenCell linesAplasiaDNA sequence polymorphism analysisEngraftmentHemoglobinuriaStem cells